Purpose in Life Survey

NCT05790278 | Enrolling By Invitation

• 1 other identifier: 1920306
• Study Type: observational
• Target: 300
• Locations: 1 country
• Sites: 1

Brief Summary

At present, there is no empirical data that specifies the likely prevalence of purpose in life disruption among various clinical populations. Between one-third and one-half of cancer survivors report some degree of existential distress during or after their treatment, but these findings are not specific to the domain of purpose in life. To address the aforementioned gap, we propose to conduct a survey study to determine the prevalence of purpose disruption in two clinical populations and determine if the prevalence of purpose disruption in these populations is different from that of a normative population.

Conditions

Breast Cancer; Traumatic Brain Injury

Outcome Measures

Primary Outcomes (1)

• Purpose Status Question

  A single forced-choice self-report screener question that we developed in order to characterize existential distress related to purpose in life (PSQ: "Related to living with purpose in life, right now I am: moving backwards; stalled; figuring it out; moving forward on a path").

  Through Study Completion, about 15 minutes

Secondary Outcomes (3)

• Work and Adjustment Scale

  Through Study Completion, about 15 minutes

• Meaning in Life Questionnaire

  Through Study Completion, about 15 minutes

• Life Engagement Test

  Through Study Completion, about 15 minutes

Study Arms (3)

Adults with Early Stage Cancer

Other: Survey

Adults with Traumatic Brain Injury

Other: Survey

Health Control Adults

Other: Survey

Interventions

Survey OTHER

Completion of a Purpose in Life Survey

Adults with Early Stage Cancer; Adults with Traumatic Brain Injury; Health Control Adults

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adults who are either (1) healthy controls, (2) individuals with a qualifying cancer diagnosis, or (3) individuals with a qualifying Traumatic Brain Injury

You may qualify if:

• Age 18+
• Stage 1, 2, 3 cancer
• Cancer types: breast cancer, non-Hodgkin's lymphoma; colorectal cancer
• Receiving oncology services or treatment through AHCI
• Have completed primary cancer treatment within the past 12 months
• Able to communicate in English;
• Able to see and read (with or without assistive devices);
• Has access to a device (computer, phone, tablet) and an email address;
• Access to an internet connection.
• Has a known email address (in EPIC) and/or home telephone number
• Adults who sustained a traumatic brain injury within the past 12 months.
• Attending the 2022 MN State Fair

You may not qualify if:

• Have declined consent for use of medical records in research during admission to AH facility

Sponsors & Collaborators

• Mary Radomski: lead

Study Sites (1)

Abbott Northwestern Hospital

Minneapolis, Minnesota, 55407, United States

Location

MeSH Terms

Conditions

Breast Neoplasms; Brain Injuries, Traumatic

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases; Brain Injuries; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Craniocerebral Trauma; Trauma, Nervous System; Wounds and Injuries

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Mary V Radomski, PhD

  Allina Health - Courage Kenny Rehabilitation Institute

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: March 10, 2023
• First Posted: March 30, 2023
• Study Start: August 1, 2022
• Primary Completion: August 31, 2023
• Study Completion: August 31, 2024
• Last Updated: February 5, 2024

Record last verified: 2024-02

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)